One exciting and developing finding is that GLP-1s can improve fertility in certain women, particularly those struggling with overweight or obesity, or who have polycystic ovary syndrome (PCOS)
This content references third-party trademarks that are the property of their respective owners
GLP-1 Gastroparesis Risks Although many different variations of GLP-1 receptor agonists have been marketed as safe and effective, concerns have emerged in recent years about painful and debilitating gastrointestinal problems from Ozempic, Wegovy and Mounjaro
241 Rodent and human studies have produced evidence that GLP-1 therapies have antiatherosclerotic and angiogenic effects, and these therapies hindered the development of diabetic cardiomyopathy
Triple peptides for the treatment of obesity Retatrutide, a single peptide linked to a fatty diacid moiety, acts as a triple-agonist targeting three receptors: GIP, GLP-1, and glucagon